OXFORD
BIOMEDICA
Oxford Biomedica Appointment of
Commercial Director
Oxford,
UK - 21 March 2000: Oxford BioMedica is pleased to announce
that Dr Paul Kenneth Durrands has agreed to join to the Board
of Oxford BioMedica as Commercial Director with special responsibility
for new corporate opportunities.
Paul
(37) trained as a Chartered Accountant with Coopers & Lybrand
and has a PhD in Molecular Biology from the University of
Bath. After qualifying as an accountant he joined BOC's distribution
division for 5 years in which time he was involved in two
acquisitions and was instrumental in winning several major
contracts. He subsequently spent 3 years as Group Finance
Director for the Pig Improvement Company (PIC), a division
of Dalgety, during which time his combination of technical
and financial expertise enabled him to integrate the newly
acquired business of the National Pig Development Company.
Paul was closely involved in the expansion of PIC into Asia
and Central Europe and in two acquisitions in Canada and Brazil.
In his most recent role as Finance Director of the joint venture
between Yoplait and Dairy Crest (YDC), Paul has been working
on the strategy and integration of the Raines Dairy Foods
business acquired by YDC prior to his appointment in 1998.
Commenting
on the appointment, Oxford BioMedica's Chief Executive, Professor
Alan Kingsman said:
"We are delighted to have attracted someone of Paul's calibre
to BioMedica. His strong commercial background combined with
his scientific experience and his proven track record in implementing
mergers and acquisitions in both the UK and abroad will be
major assets for the Company as it moves into a new era of
corporate development". |
